NCT06110793 2025-12-17A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting49 enrolled
NCT05181033 2025-07-25Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 InhibitorNational University Hospital, SingaporePhase 2 Recruiting120 enrolled